Highlights and Quick Summary
- Depreciation & Amortization for the quarter ending November 30, 2022 was $5.05 Million (a -4.58% decrease compared to previous quarter)
- Year-over-year quarterly Depreciation & Amortization increased by 7.7%
- Annual Depreciation & Amortization for 2022 was $19.6 Million (a -19.99% decrease from previous year)
- Annual Depreciation & Amortization for 2021 was $24.5 Million (a 83.22% increase from previous year)
- Annual Depreciation & Amortization for 2020 was $13.4 Million (a 98.95% increase from previous year)
- Twelve month Depreciation & Amortization ending November 30, 2022 was $19.8 Million (a 1.11% increase compared to previous quarter)
- Twelve month trailing Depreciation & Amortization decreased by -23.18% year-over-year
Trailing Depreciation & Amortization for the last four month:
| 30 Nov '22 | 31 Aug '22 | 31 May '22 | 28 Feb '22 |
|---|---|---|---|
| $19.8 Million | $19.6 Million | $26 Million | $25.8 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Depreciation & Amortization of Organigram Holdings Inc.
Most recent Depreciation & Amortizationof OGI including historical data for past 10 years.Interactive Chart of Depreciation & Amortization of Organigram Holdings Inc.
Organigram Holdings Inc. Depreciation & Amortization for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $5.05 | $5.29 | $4.78 | $4.69 | $19.58 |
| 2021 | $4.83 | $11.68 | $4.57 | $4.22 | $24.48 |
| 2020 | $4.0 | $4.3 | $3.23 | $3.28 | $13.36 |
| 2019 | $2.54 | $2.47 | $1.62 | $1.33 | $6.71 |
| 2018 | – | – | $1.29 | $7.38 | $7.38 |
| 2017 | – | – | – | – | $1.23 |
| 2016 | – | – | – | – | $0.6 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic